PUTTING PATIENTS BEFORE POLITICS - PASS ACAA

In April we sent out a call to action to contact your MEP to ask them to support the Agreement on Conformity Assessment and Acceptance of Industrial Products (ACAA) which would allow for the upgrading of the 1995 EU-Israel Association Agreement which forms the legal basis governing relations between Israel and the EU. This is mainly concerned with trade and scientific and technical cooperation and will substantially open up the European market to Israeli goods, especially pharmaceutical products. Now we are asking you to sign an online petition to ask that the European Parliament be allowed to vote on this legislation. The link to the petition is below and we urge you to please sign the petition and to send this to your friends and colleagues to ask that they do the same. 

http://www.change.org/en-GB/petitions/members-of-the-european-parliament-pass-acaa

For more than two years, opponents of the ACAA deal have delayed any action on it, preventing the issue from reaching a vote in committee and, ultimately, the plenary. Their technical and legal arguments against ACAA have all been countered by the European Council, the European Commission and the legal services of all three EU institutions—including that of the European Parliament itself.


By denying our representatives the opportunity to vote on the matter, ACAA’s critics are harming the democratic process and the interests of the very people they have been elected to serve: Europe’s citizens.


And the enormous benefits of Israeli pharmaceuticals to European healthcare and the well-being of European patients are undeniable. Despite its small size, Israel is at the forefront of major medical innovation, finding new and affordable treatments for a broad range of diseases. To name just two examples: Copaxone, the world’s top selling treatment for multiple sclerosis, was developed at the Weizmann Institute of Science in Rehovot, while the Israeli-produced generic version of Lipitor, the popular blood pressure medication, will be the first of its kind to hit the UK market, expected at a price 92% below the original.


Yes, Israeli pharmaceuticals can help us save not only lives but also costs. Teva is the world’s largest producer of generic medicines, which are critical to maintaining our high standards of healthcare, particularly during these difficult economic times. According to industry estimates, Europeans save nearly €25 billion annually by using generics, €2 billion in France alone.

The time has come to put European patients before personal politics!

CALL TO ACTION - EAPPI SYNOD MOTION

CALL TO ACTION - EAPPI SYNOD MOTION 

Ecumenical Accompaniment Programme in Palestine and Israel (EAPPI) – Motion at General Synod 2012

A motion has been tabled at the Church Of England’s General Synod  in York (10 July 2012) which seeks to formally adopt and deepen the Church’s links with the Ecumenical Accompaniment Programme in Palestine and Israel (EAPPI). The General Synod is the highest legislative body in the C of E. The motion affirms General Synod’s support for EAPPI, encourages parishioners to take part in the programme and urges Churches to make use of the experiences of returning participants. If the motion is passed it will significantly raise EAPPI’s profile and legitimacy.

What is EAPPI and why is it problematic?

EAPPI was founded in 2002. It takes around 20 Ecumenical Accompaniers (EAs) to Israel every year, for between three and four and a half months. They receive two weeks of residential training beforehand, of which just two hours is dedicated to the Israeli perspective. They volunteer in Hebron, Jayyous or Yanoun accompanying Palestinians through checkpoints and monitoring any perceived abuses. Of the three months in the region, they spend one day inside the Green Line, normally in Sderot. All of the Israeli groups they come into contact with are of the fringe left or right. They have virtually no contact with mainstream Israelis.

The result is the creation of a cohort of very partisan but very motivated anti-Israel advocates who have almost no grasp of the suffering of normal Israelis.

Participants are expected to fulfil a minimum of ten speaking engagements on their return, but most do many more in churches across the country and of all denominations. They are considered experts on the overall situation, despite having a very narrow experience which takes almost no account of the suffering of Israelis. This helps generate a climate of hostility to Israel in the churches.

What can you do?

The Church of England should be aware of the strength of feeling regarding this issue within the Jewish community. You can:

• Like the Archbishop of Canterbury’s Facebook page and comment on it, expressing your concerns regarding this motion.
• Write to the Bishop of Manchester as the chair of CCJ, expressing your concern – Bishopscourt, Bury New Road, Manchester, M7 4LE.
• Write to the Archbishop of Canterbury at Lambeth Palace, London, SE1 7JU and to William Fittall, General Secretary, The General Synod, Church House, Great Smith St, London SW1P 3AZ.
• Write to the Church Times. This is the most influential Church of England newspaper – its address is Church Times, 3rd Floor, Invicta House, 108-114 Golden Lane, London EC1Y 0TG.

When you write your letters, you may want to:

• Highlight the partisan nature of EAPPI, explaining how little time participants spend in Israel with mainstream Israelis.Remind the Church of England and members of its General Synod of their duty to examine all perspectives regarding Israel/Palestine.
• Highlight how inappropriate it would be for the General Synod to be endorsing a programme which creates entirely partisan spokespeople on the issue.
• Encourage the Synod to lend support to organisations which encourage dialogue and reconciliation, not division, such as One Voice or the Forum for Discussion of Israel/Palestine.
• Do not berate or disparage them!